J&J Expects EPO Pricing Injunction Ruling In Early 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
If the court fails to grant a preliminary injunction against Amgen, "tremendous price pressure" will be reinjected into the EPO market, the Procrit marketer tells analysts.